GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf5
|
ENSMUSG00000027186.8 | E74-like factor 5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf5 | mm10_v2_chr2_+_103424820_103424829 | -0.49 | 2.2e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_87246649 | 12.56 |
ENSMUST00000068829.5
ENSMUST00000032781.7 |
Nox4
|
NADPH oxidase 4 |
chr8_+_105131800 | 11.53 |
ENSMUST00000161289.1
|
Ces4a
|
carboxylesterase 4A |
chr7_-_119523477 | 9.15 |
ENSMUST00000033267.2
|
Pdilt
|
protein disulfide isomerase-like, testis expressed |
chr9_-_65908676 | 8.75 |
ENSMUST00000119245.1
ENSMUST00000134338.1 ENSMUST00000179395.1 |
Trip4
|
thyroid hormone receptor interactor 4 |
chr1_+_130826676 | 8.51 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr1_+_130826762 | 8.03 |
ENSMUST00000133792.1
|
Pigr
|
polymeric immunoglobulin receptor |
chr3_+_94693556 | 7.87 |
ENSMUST00000090848.3
ENSMUST00000173981.1 ENSMUST00000173849.1 ENSMUST00000174223.1 |
Selenbp2
|
selenium binding protein 2 |
chr8_-_3926798 | 6.95 |
ENSMUST00000171635.1
ENSMUST00000111014.1 ENSMUST00000084086.2 |
Cd209b
|
CD209b antigen |
chr7_+_51879041 | 6.94 |
ENSMUST00000107591.2
|
Gas2
|
growth arrest specific 2 |
chr7_+_51878967 | 6.83 |
ENSMUST00000051912.6
|
Gas2
|
growth arrest specific 2 |
chr5_-_86518578 | 6.81 |
ENSMUST00000134179.1
|
Tmprss11g
|
transmembrane protease, serine 11g |
chr8_+_107150621 | 6.79 |
ENSMUST00000034400.3
|
Cyb5b
|
cytochrome b5 type B |
chr8_+_105269837 | 6.48 |
ENSMUST00000172525.1
ENSMUST00000174837.1 ENSMUST00000173859.1 |
Hsf4
|
heat shock transcription factor 4 |
chr8_+_104733997 | 6.29 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr8_+_105269788 | 6.26 |
ENSMUST00000036127.2
ENSMUST00000163734.2 |
Hsf4
|
heat shock transcription factor 4 |
chr19_-_29047847 | 6.04 |
ENSMUST00000025696.4
|
Ak3
|
adenylate kinase 3 |
chr10_-_40025253 | 5.95 |
ENSMUST00000163705.2
|
AI317395
|
expressed sequence AI317395 |
chr15_+_9335550 | 5.66 |
ENSMUST00000072403.6
|
Ugt3a2
|
UDP glycosyltransferases 3 family, polypeptide A2 |
chr1_-_121327672 | 5.56 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr1_-_183345296 | 5.37 |
ENSMUST00000109158.3
|
Mia3
|
melanoma inhibitory activity 3 |
chr8_+_45627709 | 5.32 |
ENSMUST00000134321.1
ENSMUST00000135336.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr1_+_36761847 | 5.26 |
ENSMUST00000027291.4
|
Zap70
|
zeta-chain (TCR) associated protein kinase |
chr8_-_45333189 | 5.24 |
ENSMUST00000095328.4
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3 |
chr16_-_90934723 | 5.06 |
ENSMUST00000149833.1
|
1110004E09Rik
|
RIKEN cDNA 1110004E09 gene |
chr5_+_67260794 | 5.06 |
ENSMUST00000161369.1
|
Tmem33
|
transmembrane protein 33 |
chr3_-_67515487 | 5.04 |
ENSMUST00000178314.1
ENSMUST00000054825.4 |
Rarres1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr16_-_38522662 | 4.95 |
ENSMUST00000002925.5
|
Timmdc1
|
translocase of inner mitochondrial membrane domain containing 1 |
chr6_+_85915787 | 4.93 |
ENSMUST00000149026.1
|
Tprkb
|
Tp53rk binding protein |
chr7_+_143473736 | 4.81 |
ENSMUST00000052348.5
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr16_+_13903152 | 4.80 |
ENSMUST00000128757.1
|
Mpv17l
|
Mpv17 transgene, kidney disease mutant-like |
chr6_-_85915653 | 4.80 |
ENSMUST00000161198.2
|
Cml1
|
camello-like 1 |
chr2_-_12419456 | 4.79 |
ENSMUST00000154899.1
ENSMUST00000028105.6 |
Fam188a
|
family with sequence similarity 188, member A |
chr13_+_4228682 | 4.78 |
ENSMUST00000118663.1
|
Akr1c19
|
aldo-keto reductase family 1, member C19 |
chr1_-_121327734 | 4.76 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr7_+_105640522 | 4.66 |
ENSMUST00000106785.1
ENSMUST00000106786.1 ENSMUST00000106780.1 ENSMUST00000106784.1 |
Timm10b
|
translocase of inner mitochondrial membrane 10B |
chr13_-_41828418 | 4.60 |
ENSMUST00000137905.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr11_-_120151194 | 4.58 |
ENSMUST00000179094.1
ENSMUST00000103018.4 ENSMUST00000045402.7 ENSMUST00000076697.6 ENSMUST00000053692.8 |
Slc38a10
|
solute carrier family 38, member 10 |
chr1_-_121328024 | 4.56 |
ENSMUST00000003818.7
|
Insig2
|
insulin induced gene 2 |
chr6_-_85915604 | 4.55 |
ENSMUST00000174369.1
|
Cml1
|
camello-like 1 |
chr16_-_90934506 | 4.54 |
ENSMUST00000142340.1
|
1110004E09Rik
|
RIKEN cDNA 1110004E09 gene |
chr1_-_121327776 | 4.52 |
ENSMUST00000160688.1
|
Insig2
|
insulin induced gene 2 |
chr6_-_124741374 | 4.51 |
ENSMUST00000004389.5
|
Grcc10
|
gene rich cluster, C10 gene |
chr7_+_105640448 | 4.49 |
ENSMUST00000058333.3
|
Timm10b
|
translocase of inner mitochondrial membrane 10B |
chr11_-_84167466 | 4.44 |
ENSMUST00000050771.7
|
Gm11437
|
predicted gene 11437 |
chr16_-_90934802 | 4.43 |
ENSMUST00000023694.3
|
1110004E09Rik
|
RIKEN cDNA 1110004E09 gene |
chr15_+_99393574 | 4.43 |
ENSMUST00000162624.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr15_-_89170688 | 4.33 |
ENSMUST00000060808.9
|
Plxnb2
|
plexin B2 |
chr8_+_72219726 | 4.31 |
ENSMUST00000003123.8
|
Fam32a
|
family with sequence similarity 32, member A |
chr1_+_16688405 | 4.29 |
ENSMUST00000026881.4
|
Ly96
|
lymphocyte antigen 96 |
chr1_+_167308649 | 4.24 |
ENSMUST00000097473.4
|
Tmco1
|
transmembrane and coiled-coil domains 1 |
chr10_+_62071014 | 4.23 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr19_+_18631927 | 4.20 |
ENSMUST00000159572.1
ENSMUST00000042392.7 |
Nmrk1
|
nicotinamide riboside kinase 1 |
chr14_-_25927250 | 4.13 |
ENSMUST00000100811.5
|
Tmem254a
|
transmembrane protein 254a |
chr15_+_100304782 | 4.12 |
ENSMUST00000067752.3
|
Mettl7a1
|
methyltransferase like 7A1 |
chr16_-_44016387 | 4.04 |
ENSMUST00000036174.3
|
Gramd1c
|
GRAM domain containing 1C |
chr4_+_45848664 | 3.99 |
ENSMUST00000107783.1
|
1300002K09Rik
|
RIKEN cDNA 1300002K09 gene |
chr15_+_99393610 | 3.98 |
ENSMUST00000159531.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr15_+_99392882 | 3.97 |
ENSMUST00000023749.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr9_+_110476985 | 3.90 |
ENSMUST00000084948.4
ENSMUST00000061155.6 ENSMUST00000140686.1 ENSMUST00000084952.5 |
Kif9
|
kinesin family member 9 |
chr2_+_69135799 | 3.89 |
ENSMUST00000041865.7
|
Nostrin
|
nitric oxide synthase trafficker |
chr14_-_26066961 | 3.84 |
ENSMUST00000100818.5
|
Tmem254c
|
transmembrane protein 254c |
chr2_-_12419387 | 3.84 |
ENSMUST00000124515.1
|
Fam188a
|
family with sequence similarity 188, member A |
chr4_+_134397380 | 3.84 |
ENSMUST00000105870.1
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr9_+_7692086 | 3.82 |
ENSMUST00000018767.7
|
Mmp7
|
matrix metallopeptidase 7 |
chr10_-_95324072 | 3.79 |
ENSMUST00000053594.5
|
Cradd
|
CASP2 and RIPK1 domain containing adaptor with death domain |
chr1_-_179546261 | 3.77 |
ENSMUST00000027769.5
|
Tfb2m
|
transcription factor B2, mitochondrial |
chr10_+_75893398 | 3.73 |
ENSMUST00000009236.4
|
Derl3
|
Der1-like domain family, member 3 |
chr2_-_73386396 | 3.70 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr7_-_81454751 | 3.69 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr6_-_72362382 | 3.67 |
ENSMUST00000114095.1
ENSMUST00000069595.6 ENSMUST00000069580.5 |
Rnf181
|
ring finger protein 181 |
chr2_-_71055534 | 3.61 |
ENSMUST00000090849.5
ENSMUST00000100037.2 ENSMUST00000112186.2 |
Mettl8
|
methyltransferase like 8 |
chr7_-_79743034 | 3.56 |
ENSMUST00000032761.7
|
Pex11a
|
peroxisomal biogenesis factor 11 alpha |
chr10_-_81291227 | 3.52 |
ENSMUST00000045744.6
|
Tjp3
|
tight junction protein 3 |
chr4_+_43562672 | 3.51 |
ENSMUST00000167751.1
ENSMUST00000132631.1 |
Creb3
|
cAMP responsive element binding protein 3 |
chr3_-_53863764 | 3.49 |
ENSMUST00000122330.1
ENSMUST00000146598.1 |
Ufm1
|
ubiquitin-fold modifier 1 |
chr17_+_35470083 | 3.49 |
ENSMUST00000174525.1
ENSMUST00000068291.6 |
H2-Q10
|
histocompatibility 2, Q region locus 10 |
chr19_-_59076069 | 3.49 |
ENSMUST00000047511.7
ENSMUST00000163821.1 |
4930506M07Rik
|
RIKEN cDNA 4930506M07 gene |
chr11_-_98775333 | 3.48 |
ENSMUST00000064941.6
|
Nr1d1
|
nuclear receptor subfamily 1, group D, member 1 |
chrX_-_169320273 | 3.45 |
ENSMUST00000033717.2
ENSMUST00000112115.1 |
Hccs
|
holocytochrome c synthetase |
chr13_+_119623819 | 3.43 |
ENSMUST00000099241.2
|
Ccl28
|
chemokine (C-C motif) ligand 28 |
chrX_+_107255878 | 3.43 |
ENSMUST00000101294.2
ENSMUST00000118820.1 ENSMUST00000120971.1 |
Gpr174
|
G protein-coupled receptor 174 |
chr18_+_12599894 | 3.42 |
ENSMUST00000169401.1
|
Ttc39c
|
tetratricopeptide repeat domain 39C |
chr6_+_85915709 | 3.41 |
ENSMUST00000113751.1
ENSMUST00000113753.1 ENSMUST00000113752.1 ENSMUST00000067137.7 |
Tprkb
|
Tp53rk binding protein |
chr18_-_3337467 | 3.41 |
ENSMUST00000154135.1
|
Crem
|
cAMP responsive element modulator |
chr7_+_65693447 | 3.39 |
ENSMUST00000143508.1
|
Tm2d3
|
TM2 domain containing 3 |
chr12_+_64965742 | 3.39 |
ENSMUST00000066296.7
|
Fam179b
|
family with sequence similarity 179, member B |
chr9_-_79793507 | 3.39 |
ENSMUST00000120690.1
|
Tmem30a
|
transmembrane protein 30A |
chr18_+_56432116 | 3.38 |
ENSMUST00000070166.5
|
Gramd3
|
GRAM domain containing 3 |
chr7_-_109986250 | 3.38 |
ENSMUST00000119929.1
|
Tmem41b
|
transmembrane protein 41B |
chr3_-_89393629 | 3.38 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr9_-_106476590 | 3.37 |
ENSMUST00000112479.2
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr9_+_114731177 | 3.36 |
ENSMUST00000035007.8
|
Cmtm6
|
CKLF-like MARVEL transmembrane domain containing 6 |
chr15_+_99392948 | 3.33 |
ENSMUST00000161250.1
ENSMUST00000160635.1 ENSMUST00000161778.1 |
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr15_+_99393219 | 3.31 |
ENSMUST00000159209.1
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr9_-_79793378 | 3.29 |
ENSMUST00000034878.5
|
Tmem30a
|
transmembrane protein 30A |
chr6_+_8259288 | 3.27 |
ENSMUST00000159335.1
|
Gm16039
|
predicted gene 16039 |
chr7_-_126584578 | 3.27 |
ENSMUST00000150311.1
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr4_+_129335593 | 3.26 |
ENSMUST00000141235.1
|
Zbtb8os
|
zinc finger and BTB domain containing 8 opposite strand |
chrX_-_75843063 | 3.24 |
ENSMUST00000114057.1
|
Pls3
|
plastin 3 (T-isoform) |
chr4_+_155582476 | 3.24 |
ENSMUST00000105612.1
|
Nadk
|
NAD kinase |
chr11_+_87592145 | 3.23 |
ENSMUST00000103179.3
ENSMUST00000092802.5 ENSMUST00000146871.1 |
Mtmr4
|
myotubularin related protein 4 |
chr6_-_127109517 | 3.20 |
ENSMUST00000039913.8
|
9630033F20Rik
|
RIKEN cDNA 9630033F20 gene |
chr13_-_90089513 | 3.19 |
ENSMUST00000160232.1
|
Xrcc4
|
X-ray repair complementing defective repair in Chinese hamster cells 4 |
chr4_+_129336012 | 3.19 |
ENSMUST00000119480.1
|
Zbtb8os
|
zinc finger and BTB domain containing 8 opposite strand |
chr5_-_9161692 | 3.15 |
ENSMUST00000183973.1
ENSMUST00000184372.1 ENSMUST00000095017.4 ENSMUST00000071921.6 |
Dmtf1
|
cyclin D binding myb-like transcription factor 1 |
chr3_-_108044801 | 3.14 |
ENSMUST00000178808.1
ENSMUST00000106670.1 ENSMUST00000029489.8 |
Gstm4
|
glutathione S-transferase, mu 4 |
chrX_-_75843185 | 3.14 |
ENSMUST00000137192.1
|
Pls3
|
plastin 3 (T-isoform) |
chr7_-_126585775 | 3.12 |
ENSMUST00000084589.4
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr10_+_29313164 | 3.12 |
ENSMUST00000160399.1
|
Echdc1
|
enoyl Coenzyme A hydratase domain containing 1 |
chr9_+_44379536 | 3.09 |
ENSMUST00000161318.1
ENSMUST00000160902.1 |
Hyou1
|
hypoxia up-regulated 1 |
chr2_-_25500613 | 3.07 |
ENSMUST00000040042.4
|
C8g
|
complement component 8, gamma polypeptide |
chr5_+_67260565 | 3.07 |
ENSMUST00000037918.5
ENSMUST00000162543.1 |
Tmem33
|
transmembrane protein 33 |
chr2_-_156144138 | 3.06 |
ENSMUST00000109600.1
ENSMUST00000029147.9 |
Nfs1
|
nitrogen fixation gene 1 (S. cerevisiae) |
chr4_+_45848816 | 3.06 |
ENSMUST00000107782.1
ENSMUST00000030011.5 |
1300002K09Rik
|
RIKEN cDNA 1300002K09 gene |
chr15_+_58933774 | 3.02 |
ENSMUST00000022980.3
|
Ndufb9
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 |
chr7_+_65693417 | 3.02 |
ENSMUST00000032726.7
ENSMUST00000107495.3 |
Tm2d3
|
TM2 domain containing 3 |
chr1_-_59161594 | 3.01 |
ENSMUST00000078874.7
ENSMUST00000066374.7 |
Mpp4
|
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
chr14_+_65970804 | 2.99 |
ENSMUST00000138191.1
|
Clu
|
clusterin |
chr9_+_6168638 | 2.99 |
ENSMUST00000058692.7
|
Pdgfd
|
platelet-derived growth factor, D polypeptide |
chr5_+_67260696 | 2.99 |
ENSMUST00000161233.1
ENSMUST00000160352.1 |
Tmem33
|
transmembrane protein 33 |
chr7_+_101378183 | 2.98 |
ENSMUST00000084895.5
|
Arap1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr10_+_29313227 | 2.98 |
ENSMUST00000161605.1
|
Echdc1
|
enoyl Coenzyme A hydratase domain containing 1 |
chr10_+_19934472 | 2.96 |
ENSMUST00000095806.3
ENSMUST00000120259.1 |
Map3k5
|
mitogen-activated protein kinase kinase kinase 5 |
chr1_-_36244245 | 2.96 |
ENSMUST00000046875.7
|
Uggt1
|
UDP-glucose glycoprotein glucosyltransferase 1 |
chr7_-_99626936 | 2.95 |
ENSMUST00000178124.1
|
Gm4980
|
predicted gene 4980 |
chr1_+_58586381 | 2.93 |
ENSMUST00000027193.8
|
Ndufb3
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 |
chr19_+_8920358 | 2.93 |
ENSMUST00000096243.5
|
B3gat3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
chr11_-_105944412 | 2.93 |
ENSMUST00000019734.4
ENSMUST00000184269.1 ENSMUST00000150563.1 |
Cyb561
|
cytochrome b-561 |
chr11_-_115062177 | 2.92 |
ENSMUST00000062787.7
|
Cd300e
|
CD300e antigen |
chr10_-_41611319 | 2.92 |
ENSMUST00000179614.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chrX_-_164980279 | 2.91 |
ENSMUST00000112247.2
|
Mospd2
|
motile sperm domain containing 2 |
chr7_-_109986445 | 2.91 |
ENSMUST00000094097.5
|
Tmem41b
|
transmembrane protein 41B |
chr15_+_102102926 | 2.90 |
ENSMUST00000169627.1
ENSMUST00000046144.9 |
Tenc1
|
tensin like C1 domain-containing phosphatase |
chr15_+_88819584 | 2.87 |
ENSMUST00000024042.3
|
Creld2
|
cysteine-rich with EGF-like domains 2 |
chr19_-_11081088 | 2.87 |
ENSMUST00000025636.6
|
Ms4a8a
|
membrane-spanning 4-domains, subfamily A, member 8A |
chr17_-_78937031 | 2.86 |
ENSMUST00000024885.8
|
Cebpz
|
CCAAT/enhancer binding protein zeta |
chr9_+_108290433 | 2.83 |
ENSMUST00000035227.6
|
Nicn1
|
nicolin 1 |
chr13_+_97137937 | 2.82 |
ENSMUST00000042084.6
ENSMUST00000160139.1 ENSMUST00000161639.1 ENSMUST00000161913.1 ENSMUST00000161825.1 ENSMUST00000161929.1 ENSMUST00000022170.7 |
Gfm2
|
G elongation factor, mitochondrial 2 |
chr10_-_89732253 | 2.80 |
ENSMUST00000020109.3
|
Actr6
|
ARP6 actin-related protein 6 |
chr13_-_90089556 | 2.79 |
ENSMUST00000022115.7
|
Xrcc4
|
X-ray repair complementing defective repair in Chinese hamster cells 4 |
chr18_-_20896078 | 2.79 |
ENSMUST00000025177.6
ENSMUST00000097658.1 |
Trappc8
|
trafficking protein particle complex 8 |
chrX_-_164980310 | 2.79 |
ENSMUST00000004715.1
ENSMUST00000112248.2 |
Mospd2
|
motile sperm domain containing 2 |
chr10_+_29313500 | 2.78 |
ENSMUST00000020034.4
|
Echdc1
|
enoyl Coenzyme A hydratase domain containing 1 |
chr9_+_119102463 | 2.77 |
ENSMUST00000140326.1
ENSMUST00000165231.1 |
Dlec1
|
deleted in lung and esophageal cancer 1 |
chr14_+_65971049 | 2.76 |
ENSMUST00000128539.1
|
Clu
|
clusterin |
chr6_+_8259379 | 2.75 |
ENSMUST00000162034.1
ENSMUST00000160705.1 ENSMUST00000159433.1 |
Gm16039
|
predicted gene 16039 |
chr17_+_56005672 | 2.74 |
ENSMUST00000133998.1
|
Mpnd
|
MPN domain containing |
chr1_-_171294937 | 2.72 |
ENSMUST00000111302.3
ENSMUST00000080001.2 |
Ufc1
|
ubiquitin-fold modifier conjugating enzyme 1 |
chr15_-_55557748 | 2.72 |
ENSMUST00000172387.1
|
Mrpl13
|
mitochondrial ribosomal protein L13 |
chr1_+_74284930 | 2.72 |
ENSMUST00000113805.1
ENSMUST00000027370.6 ENSMUST00000087226.4 |
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr11_-_20112876 | 2.69 |
ENSMUST00000000137.7
|
Actr2
|
ARP2 actin-related protein 2 |
chr8_+_67494843 | 2.68 |
ENSMUST00000093470.5
ENSMUST00000163856.1 |
Nat2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
chr4_-_40722307 | 2.67 |
ENSMUST00000181475.1
|
Gm6297
|
predicted gene 6297 |
chr5_+_125389284 | 2.67 |
ENSMUST00000100700.2
|
Gm10382
|
predicted gene 10382 |
chr9_+_44379490 | 2.67 |
ENSMUST00000066601.6
|
Hyou1
|
hypoxia up-regulated 1 |
chr9_-_44965519 | 2.67 |
ENSMUST00000125642.1
ENSMUST00000117506.1 ENSMUST00000117549.1 |
Ube4a
|
ubiquitination factor E4A, UFD2 homolog (S. cerevisiae) |
chr3_-_131344892 | 2.66 |
ENSMUST00000090246.4
ENSMUST00000126569.1 |
Sgms2
|
sphingomyelin synthase 2 |
chr16_+_3872368 | 2.66 |
ENSMUST00000151988.1
|
Naa60
|
N(alpha)-acetyltransferase 60, NatF catalytic subunit |
chr1_-_106796609 | 2.65 |
ENSMUST00000112736.1
|
Vps4b
|
vacuolar protein sorting 4b (yeast) |
chr14_+_65970610 | 2.64 |
ENSMUST00000127387.1
|
Clu
|
clusterin |
chr18_-_3281036 | 2.64 |
ENSMUST00000049942.6
ENSMUST00000139537.1 ENSMUST00000124747.1 |
Crem
|
cAMP responsive element modulator |
chr2_+_126707319 | 2.64 |
ENSMUST00000028841.7
ENSMUST00000110416.2 |
Usp8
|
ubiquitin specific peptidase 8 |
chr1_-_132139605 | 2.64 |
ENSMUST00000112362.2
|
Cdk18
|
cyclin-dependent kinase 18 |
chr14_-_26206619 | 2.63 |
ENSMUST00000100806.5
|
Tmem254b
|
transmembrane protein 254b |
chr10_-_41579207 | 2.61 |
ENSMUST00000095227.3
|
Ccdc162
|
coiled-coil domain containing 162 |
chr4_+_40948401 | 2.61 |
ENSMUST00000030128.5
|
Chmp5
|
charged multivesicular body protein 5 |
chr13_+_4233730 | 2.61 |
ENSMUST00000081326.6
|
Akr1c19
|
aldo-keto reductase family 1, member C19 |
chr9_-_88438898 | 2.60 |
ENSMUST00000173011.1
ENSMUST00000174806.1 |
Snx14
|
sorting nexin 14 |
chr15_-_3979432 | 2.60 |
ENSMUST00000022791.8
|
Fbxo4
|
F-box protein 4 |
chr18_+_36783222 | 2.60 |
ENSMUST00000019287.8
|
Hars2
|
histidyl-tRNA synthetase 2, mitochondrial (putative) |
chr7_+_27195781 | 2.58 |
ENSMUST00000108379.1
ENSMUST00000179391.1 |
BC024978
|
cDNA sequence BC024978 |
chr19_+_42036025 | 2.58 |
ENSMUST00000026172.2
|
Ankrd2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
chr5_-_25100624 | 2.57 |
ENSMUST00000030784.7
|
Prkag2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr2_+_73312601 | 2.56 |
ENSMUST00000090811.4
ENSMUST00000112050.1 |
Scrn3
|
secernin 3 |
chr4_+_138879360 | 2.56 |
ENSMUST00000105804.1
|
Pla2g2e
|
phospholipase A2, group IIE |
chr19_-_23075853 | 2.55 |
ENSMUST00000181623.1
|
C330002G04Rik
|
RIKEN cDNA C330002G04 gene |
chr7_-_80232479 | 2.54 |
ENSMUST00000123279.1
|
Cib1
|
calcium and integrin binding 1 (calmyrin) |
chr9_+_107542209 | 2.53 |
ENSMUST00000010201.3
|
Nprl2
|
nitrogen permease regulator-like 2 |
chr8_+_86624043 | 2.52 |
ENSMUST00000034141.9
ENSMUST00000122188.1 |
Lonp2
|
lon peptidase 2, peroxisomal |
chr10_+_59221945 | 2.52 |
ENSMUST00000182161.1
|
Sowahc
|
sosondowah ankyrin repeat domain family member C |
chr10_-_41587753 | 2.52 |
ENSMUST00000160751.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr8_+_45627946 | 2.51 |
ENSMUST00000145458.1
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr4_+_20007938 | 2.50 |
ENSMUST00000125799.1
ENSMUST00000121491.1 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr18_-_68300329 | 2.50 |
ENSMUST00000042852.6
|
Fam210a
|
family with sequence similarity 210, member A |
chr10_-_86705485 | 2.49 |
ENSMUST00000020238.7
|
Hsp90b1
|
heat shock protein 90, beta (Grp94), member 1 |
chr9_-_42264200 | 2.48 |
ENSMUST00000169609.1
|
Sc5d
|
sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) |
chr9_+_46273064 | 2.47 |
ENSMUST00000156440.1
ENSMUST00000034583.6 ENSMUST00000114552.3 |
Zfp259
|
zinc finger protein 259 |
chr6_+_8259327 | 2.46 |
ENSMUST00000159378.1
|
Gm16039
|
predicted gene 16039 |
chr9_-_51963533 | 2.46 |
ENSMUST00000034552.6
|
Fdx1
|
ferredoxin 1 |
chr7_-_101933815 | 2.46 |
ENSMUST00000106963.1
ENSMUST00000106966.1 |
Lrrc51
|
leucine rich repeat containing 51 |
chr6_-_35539765 | 2.45 |
ENSMUST00000031866.5
|
Mtpn
|
myotrophin |
chr11_-_87987528 | 2.45 |
ENSMUST00000020775.2
|
Dynll2
|
dynein light chain LC8-type 2 |
chr19_-_7217549 | 2.45 |
ENSMUST00000039758.4
|
Cox8a
|
cytochrome c oxidase subunit VIIIa |
chr10_-_19907645 | 2.45 |
ENSMUST00000166511.1
ENSMUST00000020182.8 |
Pex7
|
peroxisomal biogenesis factor 7 |
chr9_+_123529843 | 2.44 |
ENSMUST00000026270.7
|
Sacm1l
|
SAC1 (suppressor of actin mutations 1, homolog)-like (S. cerevisiae) |
chr10_-_31445921 | 2.43 |
ENSMUST00000000305.5
|
Tpd52l1
|
tumor protein D52-like 1 |
chr3_+_94933041 | 2.43 |
ENSMUST00000090839.5
|
Selenbp1
|
selenium binding protein 1 |
chr11_-_9039585 | 2.43 |
ENSMUST00000043377.5
|
Sun3
|
Sad1 and UNC84 domain containing 3 |
chr6_+_94500313 | 2.41 |
ENSMUST00000061118.8
|
Slc25a26
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26 |
chr1_-_175491130 | 2.41 |
ENSMUST00000027812.5
|
Rgs7
|
regulator of G protein signaling 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 17.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
3.8 | 19.0 | GO:0031438 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
2.8 | 11.1 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
1.9 | 5.8 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
1.9 | 5.8 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
1.6 | 7.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
1.5 | 4.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
1.4 | 8.4 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.3 | 4.0 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.3 | 5.2 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.3 | 11.8 | GO:0071569 | protein ufmylation(GO:0071569) |
1.3 | 3.8 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
1.3 | 5.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.2 | 4.7 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
1.2 | 3.5 | GO:0019046 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) release from viral latency(GO:0019046) |
1.1 | 19.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
1.1 | 5.7 | GO:0043366 | beta selection(GO:0043366) |
1.1 | 4.5 | GO:0036343 | psychomotor behavior(GO:0036343) |
1.1 | 3.4 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
1.1 | 3.4 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
1.1 | 6.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
1.0 | 6.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.0 | 1.0 | GO:0002436 | immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
1.0 | 7.0 | GO:0001878 | response to yeast(GO:0001878) |
1.0 | 3.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.0 | 6.8 | GO:0030242 | pexophagy(GO:0030242) |
1.0 | 6.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.0 | 1.0 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.9 | 1.9 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.9 | 2.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.9 | 1.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.9 | 8.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.9 | 2.7 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.9 | 4.5 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.9 | 2.7 | GO:0019085 | early viral transcription(GO:0019085) |
0.9 | 2.6 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.9 | 4.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 3.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.8 | 2.5 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.8 | 2.5 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.8 | 4.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.8 | 4.1 | GO:0010636 | regulation of mitochondrial fusion(GO:0010635) positive regulation of mitochondrial fusion(GO:0010636) |
0.8 | 3.2 | GO:0036395 | pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) |
0.8 | 2.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 4.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.8 | 4.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.8 | 2.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.8 | 15.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.7 | 9.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 4.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.7 | 3.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.7 | 2.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
0.7 | 3.5 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.7 | 2.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 3.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 2.0 | GO:0006532 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
0.7 | 4.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.7 | 12.6 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.7 | 2.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.7 | 2.6 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.7 | 1.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.7 | 3.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.7 | 2.0 | GO:1904580 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) regulation of intracellular mRNA localization(GO:1904580) |
0.6 | 2.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.6 | 3.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 1.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.6 | 1.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.6 | 4.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.6 | 2.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.6 | 5.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 3.4 | GO:1902861 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.6 | 2.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.6 | 12.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 3.9 | GO:0021539 | subthalamus development(GO:0021539) |
0.6 | 3.3 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 1.7 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.6 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.6 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.5 | 1.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.5 | 1.6 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.5 | 2.7 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.5 | 3.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.5 | 2.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 1.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.5 | 1.6 | GO:0051030 | snRNA transport(GO:0051030) |
0.5 | 1.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 7.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 2.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 1.0 | GO:1901662 | menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 3.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 2.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 2.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 1.5 | GO:0046166 | alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.5 | 2.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 1.5 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.5 | 3.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 1.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.5 | 1.9 | GO:1903944 | skeletal muscle atrophy(GO:0014732) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.5 | 2.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 1.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.5 | 2.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 1.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.5 | 6.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 1.4 | GO:1904882 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.5 | 2.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 3.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 1.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 2.7 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.5 | 1.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.5 | 1.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.5 | 3.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 4.4 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.4 | 3.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.4 | 1.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.4 | 6.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.4 | 4.6 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.4 | 3.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.4 | 1.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.4 | 1.2 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.4 | 1.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.4 | 6.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.4 | 2.4 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.4 | 1.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 2.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.4 | 0.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.4 | 2.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 3.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.4 | 3.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 0.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 4.2 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.4 | 1.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 1.1 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.4 | 1.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 1.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 0.7 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.4 | 3.6 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.4 | 1.1 | GO:0071338 | positive regulation of hair follicle cell proliferation(GO:0071338) |
0.4 | 2.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 1.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.4 | 1.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 2.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 1.1 | GO:0048338 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.4 | 1.8 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 4.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 3.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 4.1 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.0 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.3 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 2.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 3.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 1.0 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.3 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 2.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 1.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.3 | 2.0 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.3 | 2.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.0 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 2.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.9 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.3 | 0.9 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 2.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 5.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.3 | 3.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 7.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 3.6 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 1.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 0.9 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.3 | 1.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.3 | 0.9 | GO:0016598 | protein arginylation(GO:0016598) |
0.3 | 0.9 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.3 | 5.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 0.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 1.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 11.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 2.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 0.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 1.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 1.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 0.8 | GO:0071609 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.3 | 1.9 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.3 | 18.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 2.7 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.8 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.3 | 0.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 1.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 2.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.3 | 0.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 1.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.3 | 1.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 3.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 0.8 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 0.8 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.3 | 12.7 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 7.3 | GO:0097576 | vacuole fusion(GO:0097576) |
0.3 | 0.8 | GO:0060067 | cervix development(GO:0060067) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) regulation of cell proliferation in midbrain(GO:1904933) |
0.3 | 1.5 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.2 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 1.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 1.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 8.1 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.2 | 2.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 1.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 1.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 2.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.2 | 2.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 1.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 2.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.2 | 0.5 | GO:1990839 | response to endothelin(GO:1990839) |
0.2 | 4.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 2.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 1.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 1.6 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 10.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 2.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 2.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.8 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.2 | 1.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 4.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 3.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.6 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 1.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 1.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 1.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.2 | 2.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 3.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 0.6 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.2 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.8 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.2 | 1.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 2.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 1.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 1.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.6 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.2 | 3.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 2.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 5.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 20.3 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.2 | 2.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 2.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 3.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 2.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 2.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.2 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 2.8 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 1.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.2 | 0.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 1.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 2.7 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.2 | 1.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.2 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.2 | 0.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.7 | GO:0009816 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.2 | 1.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 5.6 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.3 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.9 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 3.1 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 1.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.9 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.2 | 0.7 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
0.2 | 7.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.7 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.2 | 1.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.8 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 1.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 1.8 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 1.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 1.3 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 3.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 0.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.2 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.5 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 2.0 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 5.0 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 2.1 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 2.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 5.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 1.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.1 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.1 | 0.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 3.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.4 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 11.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 4.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.1 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 2.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 1.8 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 1.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.6 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 2.9 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 1.2 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 1.4 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 1.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 1.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 5.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 1.6 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 2.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 2.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 5.8 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 2.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 8.7 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 1.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.2 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 2.0 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 1.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 1.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 1.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 1.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 5.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 2.0 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 10.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 5.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 1.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 1.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.8 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 1.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 1.2 | GO:0098877 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.1 | 4.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 2.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 2.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 3.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 1.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0048003 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 4.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 2.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 1.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 2.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 3.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 1.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 1.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 1.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.7 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 2.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.3 | GO:0051461 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) histone H3-K27 acetylation(GO:0043974) corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.9 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.2 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 0.7 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 2.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 1.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 1.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 1.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 3.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.8 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.6 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.4 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) |
0.1 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 1.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.6 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 1.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 1.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.1 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 1.5 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 1.2 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 1.2 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 2.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.7 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.7 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 1.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 10.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 2.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 1.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 12.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 1.5 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.7 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 2.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.8 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.5 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
0.1 | 1.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 2.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.9 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 1.5 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 1.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.6 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 2.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 1.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.6 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.8 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 6.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.3 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 1.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.2 | GO:0033505 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 1.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.0 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.0 | 0.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 3.5 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 2.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 1.0 |